Correlation of c-fos and p 16 expression in oral squamous cell carcinoma with cell cycle and cell invasion

Correlation of c-fos and p16 expression in oral squamous cell carcinoma with cell cycle and cell invasion Jian Yang, Tao Yuan, Qing-Hui Meng 1. Department of Stomatology, Zaozhuang Mining Group Central Hospital in Shandong Province, Zaozhuang, Shandong Province, 277000, China 2. Electrocardiography Room, Zaozhuang Mining Group Central Hospital in Shandong Province, Zaozhuang, Shandong Province, 277000, China Journal of Hainan Medical University

[1]  G. Liao,et al.  Long non-coding RNA MALAT1 interacts with miR-124 and modulates tongue cancer growth by targeting JAG1 , 2017, Oncology reports.

[2]  Su Jin Heo,et al.  Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[3]  M. Baisakh,et al.  Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma. , 2017, Oral oncology.

[4]  P. Ramos-García,et al.  An update on the implications of cyclin D1 in oral carcinogenesis. , 2017, Oral diseases.

[5]  Zhengxue Han,et al.  Clinicopathological features, management and outcome of patients with poorly-differentiated oral and oropharyngeal squamous cell carcinoma. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[6]  Zhijun Li,et al.  Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression , 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[7]  M. Granić,et al.  Prognostic significance of extracapsular spread of lymph node metastasis from oral squamous cell carcinoma in the clinically negative neck. , 2017, International journal of oral and maxillofacial surgery.

[8]  Yaoh-Shiang Lin,et al.  Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial–mesenchymal transition-related proteins , 2017, PloS one.

[9]  K. Uchida,et al.  Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas , 2017, Veterinary pathology.

[10]  Yi Feng,et al.  Minichromosome Maintenance Complex is Required for Checkpoint Kinase 2 Chromatin Loading and its Phosphorylation to DNA Damage Response in SCC-4 Cells. , 2017, Protein and peptide letters.

[11]  V. Guddattu,et al.  The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study , 2016, Medical Oncology.

[12]  Shan Wang,et al.  Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma , 2016, Cancer investigation.

[13]  P. Angadi,et al.  Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma , 2016, International journal of surgical pathology.

[14]  M. Walton,et al.  The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma , 2015, Oncotarget.

[15]  Lei Zhang,et al.  Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[16]  K. Kao,et al.  Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1 , 2014, Journal of Experimental & Clinical Cancer Research.

[17]  T. Shibata,et al.  Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer , 2012, PloS one.